Thalidomide in the Treatment of Sweet's Syndrome and Eosinophilic Folliculitis Associated With Immune Reconstitution Inflammatory Syndrome

被引:6
作者
Dong, Rong-Jing [1 ]
Huang, Shi-Zhen [2 ]
Upadhyay, Pratishtha [1 ]
Shrestha, Samip [3 ]
Zhai, Ya-Jie [4 ]
Li, Yu-Ye [1 ]
机构
[1] Kunming Med Univ, Dept Dermatol & Venereobgy, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China
[2] Yunnan Prov Hosp Infect Dis, Airman AIDS Care Ctr YNACC, Anning, Peoples R China
[3] Kunming Med Univ, Dept Med Imaging, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China
[4] Jining Second Peoples Hosp, Dept Dermatol & Venereobgy, Jining, Peoples R China
基金
中国国家自然科学基金;
关键词
AIDS; thalidomide; sweet's syndrome; eosinophilic folliculitis; IRIS; HUMAN-IMMUNODEFICIENCY-VIRUS; NECROSIS-FACTOR-ALPHA; MATRIX METALLOPROTEINASES; CYTOKINES; DISEASE; INFECTION; ANALOGS; CELLS;
D O I
10.3389/fmed.2019.00343
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sweet's syndrome and eosinophilic folliculitis are aseptic inflammatory dermatitis mainly because of infiltrated neutrophils and eosinophils on skin, respectively. These diseases rarely overlap or coexist in the same patient, especially co-occur in HIV infected patient. Here, we report a rare case of an AIDS patient who developed eosinophilic folliculitis and Sweet's syndrome within 1 month of initial antiretroviral therapy, presumably due to immune reconstitution inflammatory syndrome. The CD4(+) T cell counts increased dramatically from 70 to 249 cells/mu L within a period of 1 month. Interestingly, the patient was rapidly and strikingly responsive to thalidomide, which has anti-inflammatory, immune regulation, inhibition of neutrophil chemotaxis etc. Moreover, we focused our attention on discussing the clinical, pathological, and possible pathogenic aspects of the rare overlap of HIV complicated with neutrophilic and eosinophilic dermatosis.
引用
收藏
页数:6
相关论文
共 39 条
  • [1] Common Variable Immunodeficiency Diagnosis, Management, and Treatment
    Abbott, Jordan K.
    Gelfand, Erwin W.
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2015, 35 (04) : 637 - +
  • [2] Eosinophils and Disease Pathogenesis
    Akuthota, Praveen
    Weller, Peter F.
    [J]. SEMINARS IN HEMATOLOGY, 2012, 49 (02) : 113 - 119
  • [3] Amerio P, 2001, ACTA DERM-VENEREOL, V81, P92, DOI 10.1080/00015550152384191
  • [4] Immune recovery inflammatory folliculitis
    Bouscarat, F
    Maubec, E
    Matheron, S
    Descamps, V
    [J]. AIDS, 2000, 14 (05) : 617 - 618
  • [5] Thalidomide in the treatment of recalcitrant Sweet's syndrome associated with myelodysplasia
    Browning, CE
    Dixon, JE
    Malone, JC
    Callen, JP
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (02) : S135 - S138
  • [6] Innovative Uses of Thalidomide
    Chen, Meng
    Doherty, Sean D.
    Hsu, Sylvia
    [J]. DERMATOLOGIC CLINICS, 2010, 28 (03) : 577 - +
  • [7] Sweet's syndrome - a comprehensive review of an acute febrile neutrophilic dermatosis
    Cohen, Philip R.
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2007, 2 (1)
  • [8] Sweet's syndrome following abacavir therapy
    Del Giudice, P
    Vandenbos, F
    Perrin, C
    Bernard, E
    MArq, L
    Dellamonica, P
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (03) : 474 - 475
  • [9] Erythema nodosum leprosum, Sweet's syndrome, and human immunodeficiency virus may be related through an overlap in immunopathogenesis
    Elbuluk, Nada
    Martiniuk, Frank
    Levis, William R.
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (11) : 1344 - 1345
  • [10] FERRANTE A, 1991, IMMUNOLOGY, V72, P440